Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058548) titled 'Development and Evaluation of a Self-medication Support Scheme Using Healthcare DX' on Nov. 1.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - Osaka Medical and Pharmaceutical University

Condition: Condition - Cold-like symptoms Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The aim of this study is to develop and empirically evaluate a self-medication support scheme utilizing healthcare digital transformation (DX) technologies, targeting individuals with cold-like symptoms. Specifically, the study involves designing and implementing a digital tool that assists individuals in appropriately assessing their symptoms and using over-the-counter (OTC) medications, while also incorporating a follow-up mechanism to monitor post-medication symptom changes and guide further self-care. The effectiveness of the scheme will be evaluated based on changes in health behavior, self-medication capability, user satisfaction, and appropriate healthcare utilization. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Pharmacists provide face-to-face symptom assessment and self-medication advice to visitors presenting with cold-like symptoms. Subsequently, visitors voluntarily report their post-medication condition and self-care status using a digital tool. This approach promotes appropriate OTC medication use, continuous monitoring of health status, and supports timely medical consultation, aiming to improve self-care abilities.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Individuals who visited a pharmacy or similar facility to purchase OTC medicines for cold-like symptoms. Individuals aged 18 years or older at the time of registration. Written informed consent has been obtained from the participant. Key exclusion criteria - Individuals under the age of 18 Those purchasing OTC medicines on behalf of someone else Individuals who do not provide written informed consent for participation in the study Target Size - 100

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 10 Month 01 Day Anticipated trial start date - 2025 Year 10 Month 01 Day Last follow-up date - 2026 Year 04 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066949

Disclaimer: Curated by HT Syndication.